2013
DOI: 10.3174/ajnr.a3463
|View full text |Cite
|
Sign up to set email alerts
|

Automated Cerebral Infarct Volume Measurement in Follow-up Noncontrast CT Scans of Patients with Acute Ischemic Stroke

Abstract: BACKGROUND AND PURPOSE:Cerebral infarct volume as observed in follow-up CT is an important radiologic outcome measure of the effectiveness of treatment of patients with acute ischemic stroke. However, manual measurement of CIV is time-consuming and operatordependent. The purpose of this study was to develop and evaluate a robust automated measurement of the CIV.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
67
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 89 publications
(70 citation statements)
references
References 17 publications
1
67
2
Order By: Relevance
“…The mTICI score is a 5-point scale, which ranges from 0 (no reperfusion) to 3 (complete antegrade reperfusion of the previously ischemic territory, with the absence of visualized occlusion in all distal branches). 27,28 Interaction between BP and IAT on safety parameters was also tested. Safety parameters included death, hemicraniectomy, SICH, and progression of ischemic stroke.…”
Section: Outcome and Safety Measuresmentioning
confidence: 99%
“…The mTICI score is a 5-point scale, which ranges from 0 (no reperfusion) to 3 (complete antegrade reperfusion of the previously ischemic territory, with the absence of visualized occlusion in all distal branches). 27,28 Interaction between BP and IAT on safety parameters was also tested. Safety parameters included death, hemicraniectomy, SICH, and progression of ischemic stroke.…”
Section: Outcome and Safety Measuresmentioning
confidence: 99%
“…7,8 Inclusion criteria for this substudy were thin-slice NCCT and CTA (<2.5 mm) performed on the same scanner within 30 minutes. Clinical outcome such as modified Rankin Scale (mRS), modified Arterial Occlusive Lesion (mAOL) score, Thrombolysis in Cerebral Infarction perfusion scale (TICI) score, and final infarct volume (FIV), 9 and baseline clinical characteristics (such as age, sex, National Institutes of Health Stroke Scale [NIHSS] score, time from onset to intravenous [IV] recombinant tissue-type plasminogen activator [r-tPA] treatment, time from onset to groin puncture, occlusion site, and atrial fibrillation) were collected during the execution of the trial. Of 248 consecutive patients with thin-slice NCCT and CTA, 10 were excluded because the time between NCCT and CTA imaging exceeded 30 minutes, 3 because CTA was performed before NCCT imaging, 3 because CTA and NCCT were performed on a different scanner, 39 because of imaging quality limitations, including movement artifacts (25), noisy NCCT image (10), incomplete region of interest (3), and CTA triggered too early or too late (1).…”
Section: Patient Selectionmentioning
confidence: 99%
“…Secondary outcome measures were the following: the absence of an intracranial occlusion on follow-up CTA and final infarct volume on follow-up NCCT. 19 For the patients who underwent successful IAT reperfusion, modified Thrombolysis in Cerebral Infarction 2B or 3 20 was also used as a secondary outcome measure. For dichotomized outcome measures, univariable logistic regression analysis was performed, and the association was presented as an OR.…”
mentioning
confidence: 99%